‘Scattershot Approach’ To Pleading Securities Claims Against Drug Maker Rejected

Mealey's (November 14, 2019, 2:16 PM EST) -- NEWARK, N.J. — A federal judge in New Jersey on Nov. 12 ruled that lead plaintiffs in a securities class action lawsuit brought against a biopharmaceutical company that develops hematology and...
To view the full article, register now.